Abstract:To explore the clinical features and long-term outcomes of patients with cblC type methylmalonic acidemia (MMA) carrying c.609G>A (p.W203X) mutation of gene. The clinical and laboratory findings of 720 patients with MMA carrying the c.609G>A mutation were retrospectively analyzed. There were 172 cases carrying homozygous mutations of c.609G>A (group A), 169 cases carrying compound heterozygous mutations of c.609G>A with c.482G>A (p.R161Q), c.80A>G or c.394C>T (p.R132X) (group B), and 379 cases carrying compound heterozygous mutations of c.609G>A with c.658_660delAAG(p.K220del), c.315A>Tor c.567dupT(p.I190fs13)(group C).The clinical manifestations, the level of blood acylcarnitine, homocysteine and urinary organic acid, and the therapeutic efficacy were compared among groups. Logistic regression was used to analyze the factors influencing the prognosis of patients. There were 306 patients (42.5%) detected from newborn screening, including 156 cases with disease onset; and 414 patients were not detected from the screening, among whom 10 cases were diagnosed by testing after the sibling confirmed, and the remaining 404 were clinical cases. In 560 patients with disease onset, the median onset age is (3 days to 20 years). The onset age of patients in group B was later than that in group A and group C (<0.01). Patients aged mostly manifested as vomiting, diarrhea, feeding difficulties and convulsions, while those year mostly manifested as movement disorders and mental retardation. Patients with renal disease all carried mutations of c.80A>G or c.482G>A, and patients with pulmonary hypertension all carried c.80A>G mutations. A total of 621 cases had long-term follow-up, 156 cases (25.1%) developed well, 433 cases (69.7%) had development delay and 32 cases (5.2%) died. The available data of 559 cases were analyzed by logistic regression, and the results showed that the neonatal screening, disease onset, age of onset and gene mutation site were significantly associated with the prognosis of patients (<0.05 or <0.01). The c.609G>A mutation in gene is associated with early-onset MMA, and most patients, clinical onset occurred within 1 month after birth. The neonatal screening and early treatment can improve the prognosis of patients,whereas clinical onset is unfavorable for prognosis. Patients with c.609G>A homozygous mutation have a worse prognosis than those with the compound heterozygous mutation of c.609G>A with other mutations.

[Analysis of 12 cases with methylmalonicacidemia cblA type].

Clinical Characteristics and Genotype Analysis of Five Infants with Cblx Type of Methylmalonic Acidemia

Clinical and genetic analysis of methylmalonic aciduria in 60 patients from Southern China: a single center retrospective study

Clinical analysis and outcome of patients with c. 482G >A variant of MMACHC gene in cblC type methylmalonic acidemia

Phenotypic and genotypic analysis of children with methylmalonic academia: A single-center study in China and a recent literature review

Analysis of MUT gene mutations in a patient with isolated methylmalonic acidemia]

Clinical characteristics and gene mutation analysis of methylmalonic aciduria

Case Report: A Case of Adult Methylmalonic Acidemia With Bilateral Cerebellar Lesions Caused by a New Mutation in MMACHC Gene

Clinical Features and Outcomes of Patients with Cblc Type Methylmalonic Acidemia Carrying Gene C.609g>a Mutation.

Evaluation of the Clinical, Biochemical, Genotype and Prognosis Ofmut-Type Methylmalonic Acidemia in 365 Chinese Cases

[Analysis of the MUT gene mutations in patients with methylmalonic acidemia].

A Study on a Cohort of 301 Chinese Patients with Isolated Methylmalonic Acidemia

Clinical, Biochemical, and Molecular Analysis of Combined Methylmalonic Acidemia and Hyperhomocysteinemia (cblc Type) in China

Evaluation of the clinical, biochemical, genotype and prognosis of mut-type methylmalonic acidemia in 365 Chinese cases

Long-term follow-up of Chinese patients with methylmalonic acidemia of the cblC and mut subtypes

Mutation analysis, treatment and prenatal diagnosis of Chinese cases of methylmalonic acidemia

Clinical and Molecular Genetic Analysis with Methylmalonic Acidemia Combined with Homocystinuria

Biochemical, Molecular and Outcome Analysis of Eight Chinese Asymptomatic Individuals with Methyl Malonic Acidemia Detected Through Newborn Screening

The First Case of Cobalamin F Disorder in China: Report and Literature Review

Mutation Spectrum of MMACHC in Chinese Patients with Combined Methylmalonic Aciduria and Homocystinuria

Clinical data analysis of cblC methylmalonic acidemia combined with homocysteinemia